Schonfeld Strategic Advisors LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 60 filers reported holding LEAP THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$17,238
-27.9%
50,700
-4.5%
0.00%
Q4 2022$23,895
-48.1%
53,100
+1.9%
0.00%
Q3 2022$46,000
-23.3%
52,100
+0.2%
0.00%
-100.0%
Q2 2022$60,000
-31.0%
52,000
+5.7%
0.00%0.0%
Q1 2022$87,000
-24.3%
49,200
+39.4%
0.00%0.0%
Q4 2021$115,000
-19.0%
35,3000.0%0.00%0.0%
Q3 2021$142,000
-91.5%
35,300
-95.6%
0.00%
-95.5%
Q2 2020$1,670,000
+1755.6%
798,676
+894.4%
0.02%
+1000.0%
Q4 2019$90,0000.0%80,319
+4.3%
0.00%
-33.3%
Q3 2019$90,00077,0190.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 476,223$533,0000.13%
683 Capital Management, LLC 150,142$168,0000.02%
Alyeska Investment Group, L.P. 514,285$576,0000.01%
Baker Brothers Advisors 978,454$1,096,0000.01%
Quilter Plc 50,000$56,0000.00%
Schonfeld Strategic Advisors LLC 80,319$90,0000.00%
FMR LLC 660,800$740,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Lionsbridge Wealth Management LLC 181$00.00%
GEODE CAPITAL MANAGEMENT, LLC 328,986$368,0000.00%
View complete list of LEAP THERAPEUTICS INC shareholders